Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College, London
European Organisation for Research and Treatment of Cancer - EORTC
University College, London
Children's Oncology Group
Children's Oncology Group
M.D. Anderson Cancer Center
Children's Oncology Group
Maria Sklodowska-Curie National Research Institute of Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)